skip to Main Content

Safeguarding continuity of care in the UK during the pandemic

As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published guidelines cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in the delivery of care for cardiovascular disease…

First step towards the Asia-Pacific region

FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health last week. As the first…

FibriCheck guards you while you sleep

Night monitoring now closer than ever after successful beta test If you’re familiar with atrial fibrillation, you’ll know it can be a dangerous condition – the heart rhythm disorder is responsible for around 25% of all strokes1. You’ll also know…

Guaranteeing continuity of care during the lockdown and beyond

TeleCheck-AF remote screening project goes live across Europe It’s no secret the COVID-19 pandemic is placing enormous pressure on our healthcare system. Capacity in our hospitals and clinics is stretched thin. And some patients may find it hard to get…

FibriCheck selected to join the NHS Innovation Accelerator

FibriCheck has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020   FibriCheck is thrilled to be among the new innovations joining the 2020 NIA programme. FibriCheck is an innovative, hardware-free…

What is atrial fibrillation?

Atrial fibrillation or AF is the most common heart rhythm disorder and is defined by its irregular and often accelerated heart beat. Untreated atrial fibrillation increases the chance for certain serious disorders like stroke, heart failure, diabetes, dementia and hypertension.…

Back To Top
Search